NCT00002792
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +23 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Myelodysplastic-Myeloproliferative Diseases
Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.
154 public trials
19 recruiting studies
Myelodysplastic-Myeloproliferative Diseases trial results
NCT00255710
- Conditions
- Amyloidosis, Anemia, Anemia, Refractory, +66 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00015925
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +43 more
- Locations
-
- Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Completed
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00006042
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00004871
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +18 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00003243
- Conditions
- Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +41 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00077558
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +42 more
- Locations
-
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
- Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States
Active, Not Recruiting
Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
NCT05600894
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UCI Health Laguna Hills Laguna Hills, California, United States
Active, Not Recruiting
Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes
NCT05038592
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
NCT03289910
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid Leukemia, +32 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States